标题
An Update on the Current State of Management and Clinical Trials for IgA Nephropathy
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 10, Issue 11, Pages 2493
出版商
MDPI AG
发表日期
2021-06-04
DOI
10.3390/jcm10112493
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SGLT-2 inhibition in IgA nephropathy: the new standard of care?
- (2021) Jonathan Barratt et al. KIDNEY INTERNATIONAL
- A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
- (2021) David C. Wheeler et al. KIDNEY INTERNATIONAL
- POS-830 NEFECON FOR THE TREATMENT OF IgA NEPHROPATHY IN PATIENTS AT RISK OF PROGRESSING TO END-STAGE RENAL DISEASE: THE NEFIGARD PHASE 3 TRIAL RESULTS
- (2021) J. BARRATT et al. Kidney International Reports
- After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.
- (2020) Thomas Rauen et al. KIDNEY INTERNATIONAL
- MO039THE 24-WEEK INTERIM ANALYSIS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY OF ATACICEPT IN PATIENTS WITH IGA NEPHROPATHY AND PERSISTENT PROTEINURIA
- (2020) Jonathan Barratt et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy
- (2020) Richard Lafayette et al. Kidney International Reports
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Why Target the Gut to Treat IgA Nephropathy?
- (2020) Jonathan Barratt et al. Kidney International Reports
- Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
- (2019) Aliza Thompson et al. Clinical Journal of the American Society of Nephrology
- Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- (2019) Jürgen Floege et al. KIDNEY INTERNATIONAL
- A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy
- (2019) James R. Myette et al. KIDNEY INTERNATIONAL
- New strategies and perspectives on managing IgA nephropathy
- (2019) Haresh Selvaskandan et al. Clinical and Experimental Nephrology
- Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial
- (2019) Li-Jun Liu et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study
- (2019) Tong-dan Bi et al. BMC Nephrology
- Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1
- (2019) Dana V. Rizk et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- IgA nephropathy: new insights into the role of complement
- (2018) Jürgen Floege et al. KIDNEY INTERNATIONAL
- Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy
- (2018) Rosanna Coppo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- FP110A PHASE 2 TRIAL OF THE SAFETY AND EFFICACY OF BARDOXOLONE METHYL IN PATIENTS WITH RARE CHRONIC KIDNEY DISEASES
- (2018) Pablo Pergola et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy
- (2018) Yukihiko Kawasaki et al. PEDIATRICS INTERNATIONAL
- Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases
- (2018) József Dobó et al. Frontiers in Immunology
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
- (2018) Howard Trachtman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
- (2017) Jicheng Lv et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Deletion Variants ofCFHR1andCFHR3Associate with Mesangial Immune Deposits but Not with Progression of IgA Nephropathy
- (2017) Perrine Jullien et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mucosal corticosteroid therapy of IgA nephropathy
- (2017) Jürgen Floege KIDNEY INTERNATIONAL
- Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
- (2017) Bengt C Fellström et al. LANCET
- The renaissance of complement therapeutics
- (2017) Daniel Ricklin et al. Nature Reviews Nephrology
- TO012C5A RECEPTOR INHIBITOR AVACOPAN IN IGA NEPHROPATHY STUDY
- (2017) Annette Bruchfeld et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- New insights into the pathogenesis of IgA nephropathy
- (2017) See Cheng Yeo et al. PEDIATRIC NEPHROLOGY
- First Treatment of Relapsing Rapidly Progressive IgA Nephropathy With Eculizumab After Living Kidney Donation: A Case Report
- (2017) A.L. Herzog et al. TRANSPLANTATION PROCEEDINGS
- Therapeutic Inhibition of Complement: Well Worth the Risk
- (2017) Scott R. Barnum TRENDS IN PHARMACOLOGICAL SCIENCES
- Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy
- (2016) Masahiro Muto et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fine Mapping Implicates a Deletion of CFHR1 and CFHR3 in Protection from IgA Nephropathy in Han Chinese
- (2016) J. Xie et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
- (2016) Richard A. Lafayette et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
- (2016) Ya-Ling Zhai et al. MEDICINE
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of complement in IgA nephropathy
- (2015) Mohamed R. Daha et al. JOURNAL OF NEPHROLOGY
- Current Understanding of the Role of Complement in IgA Nephropathy
- (2015) N. Maillard et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression
- (2015) Stephen P. McAdoo et al. KIDNEY INTERNATIONAL
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
- (2015) Thomas Rauen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement System Part I – Molecular Mechanisms of Activation and Regulation
- (2015) Nicolas S. Merle et al. Frontiers in Immunology
- Association of C4d Deposition with Clinical Outcomes in IgA Nephropathy
- (2014) M. Espinosa et al. Clinical Journal of the American Society of Nephrology
- Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy
- (2014) L. Zhu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
- (2014) Krzysztof Kiryluk et al. NATURE GENETICS
- Eculizumab treatment for rescue of renal function in IgA nephropathy
- (2014) Therese Rosenblad et al. PEDIATRIC NEPHROLOGY
- Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch–Schönlein purpura and primary IgA nephropathy
- (2014) Maria Elena Donadio et al. PEDIATRIC NEPHROLOGY
- C3a, C5a Renal Expression and Their Receptors are Correlated to Severity of IgA Nephropathy
- (2013) Lu Liu et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features
- (2013) Gang Xin et al. JOURNAL OF NEPHROLOGY
- Role of Nrf2 in protection against acute kidney injury
- (2013) Luke M. Shelton et al. KIDNEY INTERNATIONAL
- IgA Nephropathy
- (2013) Robert J. Wyatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelin antagonists for diabetic and non-diabetic chronic kidney disease
- (2012) Donald E. Kohan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Spleen Tyrosine Kinase Is Important in the Production of Proinflammatory Cytokines and Cell Proliferation in Human Mesangial Cells following Stimulation with IgA1 Isolated from IgA Nephropathy Patients
- (2012) M. J. Kim et al. JOURNAL OF IMMUNOLOGY
- The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
- (2012) Na Zhao et al. KIDNEY INTERNATIONAL
- Decreased Circulating C3 Levels and Mesangial C3 Deposition Predict Renal Outcome in Patients with IgA Nephropathy
- (2012) Seung Jun Kim et al. PLoS One
- Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis
- (2012) Krzysztof Kiryluk et al. PLoS Genetics
- Chapter 10: Immunoglobulin A nephropathy
- (2012) Kidney International Supplements
- The gut as communicator between environment and host: Immunological consequences
- (2011) Per Brandtzaeg EUROPEAN JOURNAL OF PHARMACOLOGY
- Mice overexpressing BAFF develop a commensal flora–dependent, IgA-associated nephropathy
- (2011) Douglas D. McCarthy et al. JOURNAL OF CLINICAL INVESTIGATION
- Genome-wide association study identifies susceptibility loci for IgA nephropathy
- (2011) Ali G Gharavi et al. NATURE GENETICS
- New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria
- (2011) H. K. Smerud et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function
- (2011) Kisara Onda et al. BMC Nephrology
- Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy
- (2010) A. C. ALLEN et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy
- (2009) C. Manno et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Immune complex formation in IgA nephropathy: a case of the 'right' antibodies in the 'wrong' place at the 'wrong' time?
- (2009) J. Barratt et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Levels of Urinary Complement Factor H in Patients with IgA Nephropathy are Closely Associated with Disease Activity
- (2009) J.-J. Zhang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Combination Therapy of Prednisone and ACE Inhibitor Versus ACE-Inhibitor Therapy Alone in Patients With IgA Nephropathy: A Randomized Controlled Trial
- (2008) Jicheng Lv et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Increase in B-cell-activation factor (BAFF) and IFN-γ productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy
- (2008) Takashi Goto et al. CLINICAL IMMUNOLOGY
- Toll-Like Receptor 9 Affects Severity of IgA Nephropathy
- (2008) H. Suzuki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mesangial C4d deposition: a new prognostic factor in IgA nephropathy
- (2008) M. Espinosa et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now